Details for 2010782116
Up to date per 01.04.2026
Actions
Details for 2010782116
Granted/Registered
European Patent
19.09.2012 A
01.08.2018 B1
13.11.2009
US
261173 P
A61K 9/20 20060101AFI20120531BHEP
Owner
AstraZeneca AB 151 85 SödertäljeSE
AstraZeneca UK Limited1 Francis Crick Avenue Cambridge Biomedical Campus Cambridge CB2 0AAGB
Representative
Representative
Häupl & Ellmeyer KG PatentanwaltskanzleiMariahilfer Straße 50 (Kirchengasse 1)1070 WienAT
Inventor
HALLGREN, AgnetaC/o Astrazeneca R&D Molndal 431 83 MolndalSE
SWENSON, Ralf Magnus Wernerc/o Astrazeneca R&d Molndal 431 83 MolndalSE
Information about Fees